93 related articles for article (PubMed ID: 1797829)
1. Determination of the new morpholino anthracycline MX2.HCl and its metabolites in biological samples by high-performance liquid chromatography.
Shinkai H; Takahashi H; Kikuchi K; Kawai H; Otake N
J Chromatogr; 1991 Sep; 570(1):203-8. PubMed ID: 1797829
[TBL] [Abstract][Full Text] [Related]
2. Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids.
Oosterbaan MJ; Dirks RJ; Vree TB; van der Kleijn E
J Chromatogr; 1984 Mar; 306():323-32. PubMed ID: 6585367
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of MX2, a new morpholino anthracycline, in CSF following intravenous injection].
Yamamoto H; Arita N; Ohnishi T; Hiraga S; Izumoto S; Taki T; Higuchi M; Hayakawa T; Shinkai H
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1227-30. PubMed ID: 8333749
[TBL] [Abstract][Full Text] [Related]
4. Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatography.
Maessen PA; Mross KB; Pinedo HM; van der Vijgh WJ
J Chromatogr; 1987 Jul; 417(2):339-46. PubMed ID: 3477566
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
[TBL] [Abstract][Full Text] [Related]
6. Fully automated determination of a new anthracycline N-l-leucyldoxorubicin and six metabolites in plasma by high-performance liquid chromatography with on-line sample handling.
de Jong J; Munniksma CN; Guérand WS; Bast A; van der Vijgh WJ
J Chromatogr; 1992 Feb; 574(2):273-81. PubMed ID: 1618960
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
Park SJ; Kaye AH; Hill JS
J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
[TBL] [Abstract][Full Text] [Related]
8. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
[TBL] [Abstract][Full Text] [Related]
10. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Arai Y; Kitai R
Neurol Res; 1994 Aug; 16(4):257-64. PubMed ID: 7984256
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R; Uno H; Kodera T
No To Shinkei; 1995 Oct; 47(10):969-73. PubMed ID: 7577142
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of a new anthracycline, DA-125, and its metabolites M1, M2, M3 and M4 in plasma and urine by high-performance liquid chromatography.
Shim HJ; Lee ED; Yoon EJ; Lee SD; Kim WB; Yang J; Lee MG
J Chromatogr B Biomed Appl; 1994 Jun; 656(2):407-14. PubMed ID: 7987494
[TBL] [Abstract][Full Text] [Related]
14. Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2.
Komeshima N; Kawai H; Nakajima S; Watanabe M; Tsuruo T; Takeuchi T; Otake N
J Antibiot (Tokyo); 1989 Sep; 42(9):1424-9. PubMed ID: 2793595
[TBL] [Abstract][Full Text] [Related]
15. Sensitive method for the determination of daunorubicin and all its known metabolites in plasma and heart by high-performance liquid chromatography with fluorescence detection.
de Jong J; Maessen PA; Akkerdaas A; Cheung SF; Pinedo HM; van der Vijgh WJ
J Chromatogr; 1990 Aug; 529(2):359-68. PubMed ID: 2229255
[TBL] [Abstract][Full Text] [Related]
16. New method for the determination of doxorubicin, 4'-epidoxorubicin and all known metabolites in cardiac tissue.
Maessen PA; Pinedo HM; Mross KB; van der Vijgh WJ
J Chromatogr; 1988 Jan; 424(1):103-10. PubMed ID: 3163337
[TBL] [Abstract][Full Text] [Related]
17. Determination of lefucoxib in rat plasma, urine, and feces by high-performance liquid chromatography with fluorescence detection: application in pharmacokinetic studies.
Bi X; Meng Z; Dou G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):199-205. PubMed ID: 17161982
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
[TBL] [Abstract][Full Text] [Related]
19. Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography.
Deesen PE; Leyland-Jones B
Drug Metab Dispos; 1984; 12(1):9-13. PubMed ID: 6141919
[TBL] [Abstract][Full Text] [Related]
20. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection.
Igarashi K; Castagnoli N
J Chromatogr; 1992 Sep; 579(2):277-83. PubMed ID: 1429975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
